Abstract: BACKGROUND: Dermatomyositis affects striated muscles, skin and other organs. OBJECTIVE: To characterize the disease from January 1992 to December 2002, assessing its classification, cutaneous and systemic manifestations, and also laboratory results, therapeutic and prognostic findings compared to those in the literature. METHODS: Data were obtained from medical records of 109 patients who were classified into five groups: 23 juvenile dermatomyositis; 59 primary idiopathic dermatomyositis; 6 amyopathic dermatomyositis; 7 dermatomyositis associated with neoplasms and 14 dermatomyositis associated with other connective tissue diseases. RESULTS: Sixty patients were classified as "definite" diagnosis; 33 as "possible"; four as "probable" and 12 and as amyopathic. The average age at diagnosis was 36 years. Cutaneous manifestations occurred in all patients; the most frequent symptom was loss of proximal muscle strength; the most common pulmonary disorder was interstitial lung disease, and gastritis was the most prevalent digestive manifestation. Tumors were documented in 6.42% of cases. Lactate dehydrogenase was the muscle enzyme most frequently elevated in the majority of cases. Skin biopsies were performed in 68 patients; muscle biopsies in 53; and electroneuromyographies in 58 patients. The most commonly used treatment was corticotherapy and the mortality rate was 14.7%. CONCLUSION: in this sample, the disease appeared in younger individuals, was more frequent in women and the association with cancer was small.
INTRODUCTION
Dermatomyositis (DM) is a connective tissue disease that combines myopathy and distinctive skin manifestations. Etiological aspects including associations with histocompatibility antigens, viruses, drugs and autoimmunity have been considered.
1,2
The disease affects twice as many women than men and can occur at any age, although it most often appears between 40 and 60 years. The diagnosis of juvenile DM (JDM) usually occurs between five and 14 years of age, without gender predominance and with better prognosis compared to adult patients. 2, 3 Bohan and Peter 4 published a classification for DM, which was revised in 1996 by Drake et al. 5 The disease is divided into two categories: without muscle involvement (amyopathic DM or DM without myositis) and with muscle involvement (adult DM -associated or not with cancer -, juvenile DM and overlap syndrome).
Cutaneous manifestations of DM are grouped into pathognomonic (Gottron's papules and Gottron's sign), characteristic (shawl sign, heliotrope, periun-
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Vitor Manuel Silva dos Reis 1 ciation of immunosuppressants such as methotrexate, azathioprine, cyclophosphamide, mycophenolate mofetil, chlorambucil, cyclosporine or immunobiological drugs, is required. 1, 6 Prognosis depends on several factors such as, patient's age, severity of myositis, presence of dysphagia, cardiopulmonary involvement and association with neoplasms, early diagnosis and treatment, in addition to patient's response to treatment with corticosteroids. 5 This study is a clinical-epidemiological study of patients with DM seen at the Dermatology and Rheumatology Services at São Paulo University (USP) Medical School Clinics Hospital.
MATERIALS AND METHODS
We reviewed the medical records of patients from the Dermatology and Rheumatology Clinics, at São Paulo University (USP) Medical School Clinics Hospital, from January 1992 to December 2002, including in this study 109 patients with the diagnosis of DM confirmed by clinical and laboratory findings.
Medical records were evaluated regarding age at disease onset, gender, race, clinical presentation, cutaneous lesions, association with other systemic diseases and neoplasms, complementary tests, systemic complications and performed treatments.
Only patients with confirmed diagnosis of DM were included in the study, with individuals still under investigation and those in which evolution and laboratory tests pointed to other diseases being excluded from it.
Laboratory tests were considered abnormal above the following values for CK, ALT, AST, LDH and aldolase, respectively: 234 nm/ml, 456 ng/ml, 345 ng/ml, 222 ng/ml and 333 ng/ml. We adopted the criteria for diagnosis and classification of DM/PM proposed by Bohan and Peter in 1975 , and patients were divided into three groups with possible, probable and definite diagnosis and subsequently classified as juvenile DM (defined as disease start up to 18 years of age), primary idiopathic DM, DM associated with other connective tissue diseases, DM associated with malignancies and amyopathic DM, in which patients had typical manifestations without clinical or laboratory findings of muscle involvement within six months from the detection of cutaneous lesions. 4 After this distribution, characteristics such as age, gender and race were evaluated for each group.
Once again, patients were separated into two groups: juvenile DM and adult DM, with the description of cutaneous and muscle characteristics, digestive and pulmonary systems disorders, laboratory tests results (muscle enzymes, ANA, anti-jo-1 antibodies) and other complementary tests (anatomopathological examination of cutaneous and muscle lesions, and electroneuromyography). Patients' treatments and outcomes were also described, in addition to the causes of death.
The homogeneity test was used to compare two populations: adult and juvenile DM, regarding the presence of mucin in the dermis during histopathological examination of cutaneous biopsies.
The goals of this study were to demonstrate the characteristics of patients with DM treated in our service and evaluate the laboratory tests ordered by the medical team. males, with ages varying between 20 and 75 years (mean 42 and standard deviation 15 years).
Adult DM was diagnosed in eight patients. One case was associated with connective tissue disease and another with neoplasm. Adding the adult and juvenile ADM, we detected a total of 12 patients (11%) during the study period. Nine were females (75%) and three males (25%), with ages varying between eight and 73 years (mean age: 32). Eight patients were white, two black and two were dark-skinned.
Association between DM and connective tissue diseases was found in 14 cases (12.84%), ( Table 2) . Amongst them, 12 were women (85.7%) and two were men (14.3%), aged between 22 and 71 years (mean age: 41). Eight patients were white, three were black and two dark-skinned. The disease most often associated with DM was scleroderma, with seven cases (50%), followed by systemic lupus erythematosus (SLE) and Sjögren's syndrome, each with three cases (21.4%), and rheumatoid arthritis, with two cases (14.3%), (Graph 2). One patient had association of DM, SLE and rheumatoid arthritis.
Neoplasms associated to DM were diagnosed in seven cases (6.42%), four female patients (57%) and three males (42.85%), aged between 31 and 83 years (mean age: 73 years). The most affected ethnic group was Caucasian, with six cases; only one patient was dark-skinned. The identified neoplasms were: nasopharyngeal lymphoepithelioma, tubular adenocarcinoma of the rectum and cervix, ovarian, gastric, breast and prostate carcinomas. All affected patients died from tumor progression (Table 3) .
In the patient sample studied, we found 86 cases of adult DM (79%) and 23 cases of JDM (21%). Table 4 describes the cutaneous alterations found in each group. The most common lesion was heliotrope, found in 74 patients (67.9%), followed by the Gottron's signal/papules (67%), photosensitivity (54.1%) and poikiloderma (53.2%). Raynaud's phenomenon, purpura, hand edema and panniculitis did not occurred in JDM. Cutaneous calcifications were more frequent in JDM (26%) than in adult DM; among the latter, calcifications occurred in only three individuals (3.5%). A case of hypertrichosis was found in a patient with JDM. Strength loss was the most common muscle symptom observed, occurring in 96 subjects (88%), followed by arthralgia (30.2%), myalgia (12.8%) and arthritis (8.25%). Muscle contracture occurred in one patient with JDM (Graph 3).
Among the 109 cases, 31 lung abnormalities were observed, the most frequent ones being interstitial lung disease, diagnosed in 19 patients (17.4%), and bacterial pneumonia in eight cases (7.3%), (Table 5) .
Gastrointestinal tract disorders are described in graph 4. Gastritis occurred in 22 patients (20.2%) and one case of intestinal vasculitis was diagnosed in a patient with JDM.
Of all muscle enzymes tested, DHL was elevated in the majority of patients (78.6%). It was followed by alterations in AST (57.7%), aldolase (57.35%), CK (54.3%) and ALT (50%), (Table 6 ). ANA was requested for 97 patients of which 68 (70%) had a positive test, with 56 cases presenting a speckled pattern (82.3%), eight with homogeneous (11.8%) and three with nucleolar patterns (4, 4%) and one case with centromere pattern (1.5%). Of the 37 anti-Jo-1 antibody tests requested, four (10.8%) were positive (Table 7) .
Sixty-eight skin biopsies with histopathologic examination (62% of cases) were performed: 53 exams were compatible with DM (78%) and 27 samples had mucin in the dermis (39.7%), this feature being most noticeable in JDM, with 10 cases in 16 biopsies (62.5%). Muscle biopsies were requested for 53 patients (48.6% of cases), with results consistent with DM in 51 cases (96%). Of the 58 electroneuromyographies (EMG) performed (53%), 47 (81%) had typical DM abnormalities (Table 8) . Table 9 details the use of corticosteroids in 102 patients (93.5%) and chloroquine in 55 individuals (50.4%), with methotrexate being the most widely used immunosuppressive agent (37 patients -34%).
Eighty-nine patients evolved with clinical improvement (81.6%), four were cured when discharged (3.67%) and 16 died (14.7%), (Graph 5). Two deaths occurred in JDM patients (8.7%), caused by gastrointestinal bleeding and pneumonia, and 14 in adult patients with DM (16.3%), seven deaths were caused by internal neoplasms, three by pneumonia, three by septicemia and one by tuberculosis (Graph 6). Females were the most affected ones (p <0.0001), similarly to other retrieved studies.
7,10-17 The group of patients with dermatomyositis associated with neoplasms (NDM) had equal proportions of men and women, but in all other groups, females were more affected.
The average age at disease onset was 36 years, demonstrating the occurrence of DM in young individuals and drawing attention to the need of further and larger studies, regarding the genetic and environmental factors that favor an earlier onset of the disease in this country, since in other reviewed studies, it occurred most often between 45 and 65 years of age. 18, 19 Patients with PIDM were the most frequently observed ones, in consonance with the works of Benbassat et al. and Parodi et al. 20, 21 Several authors studied JDM and their data are similar to these, except for the study by Chowdhary et al. , which demonstrated predominance of males over females, possibly due to the small sample size (12 boys and seven girls). 15, [22] [23] [24] [25] [26] [27] [28] [29] Diagnostic criteria for ADM vary depending on the study analyzed and disease prognosis is unclear. El-Azhary and Pakzad found 37 ADM cases among 746 DM patients (5% of the sample).
30 Twenty-eight GRAPH 6: Dermatomyositis and causes of death patients were males and nine were females (3:1). Five patients (13%) presented associated malignancy. Thirteen of the 157 patients with DM evaluated by Caproni et al. had ADM (8.2%) . 31 Twelve of them were females and only one was male, with nine cases presenting associated cancer. Cosnes et al. evaluated 63 patients with DM and found 12 ADM cases. 32 Ten of those were adults and one was a child; one association with malignancy was diagnosed and there was a predominance of females, with 11 cases. In this study, four of 12 patients were younger than 18 years, one had a coexisting connective tissue disease and another had concomitant prostate carcinoma; female gender was more frequent with nine cases detected. In this sample, ADM was slightly associated with neoplasms.
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Dermatomyositis associated with connective tissue disease (CDDM) occurred in 12.84% of the cases, contrasting only with the study by Tymms and Webb, in which 43 of 105 patients had other concomitant connective tissue diseases (41%).
8 Scleroderma was the connective tissue disease most frequently associated with DM, ratifying the findings of Trueb, with a prevalence of females, representing 85.76% of the cases, similar to all reviewed studies. 33 Large works describe the incidence of DM with coexisting neoplasms as varying between 6 and 60% of cases, with an average of 15 to 30%. [34] [35] [36] Not all authors, however, recognize this association. Overall, any study that attempts to analyze the link between DM and cancer faces the problem of DM's low frequency, which causes most reviews to be based on retrospective studies, with all the implicit limitations, whilst prospective series lack sufficient cases to provide statistically significant results.
There are conflicting factors in this classification, such as: a more frequent association of DM and neoplasm after age 60, malignant tumors induced by the therapeutic use of immunosuppressive drugs and the fact that more tests are conducted to rule out the disease in patients within this age range. 37 We should keep in mind the proper timing and manner of scanning for neoplasms, both in clinical and economic terms.
A large study performed in Europe evidenced a strong association between DM and increased risk of cancer. The authors found 618 patients with DM, 198 of which developed cancer after the diagnosis. 36 In Australia, the study on malignancy incidence in inflammatory myopathies found that DM was the one with the strongest association. 38 The link between DM and cancer found in this study was small, compared to other published results. 17, 20, [39] [40] [41] [42] [43] [44] [45] [46] [47] A study conducted in Brazil by Scola et al. 13 found only four cases of neoplasm in 59 patients with DM (6.8%) and the current study detected seven cancer cases in 109 patients (6.42%). Of all the patients with NDM, four were women and three were men, unlike other DM groups, in which female rates far exceeded the male ones, however, the statistical analysis of these data was not significant. This may corroborate the works by Basset-Seguin et al. 48 and Gallais et al. 40 , in which the authors suggest the male gender as a risk factor for the association of DM with cancer. Nonetheless, Wataka et al. indicated the female gender as a risk factor for the development of neoplasms.
49
The highest incidence of NDM occurred after the age of 60, comprising five of the seven cases reported (71.4%), confirming the findings by Wong, Marie et al. and Staves et al., One case of nasopharyngeal cancer, an association commonly reported in Asian patients, was diagnosed. 16, [53] [54] [55] In the work conducted by Basset-Seguin et al., there was 100% mortality in this group and the same occurred in our study.
48
Regarding cutaneous alterations, both in JDM as in adult DM, we found a higher frequency of classical signs of the disease, such as: heliotrope, Gottron's papules/sign, poikiloderma and photosensitivity. We cannot, however, disregard other very common nonspecific alterations in DM, such as thinning hair in adults and scalp desquamation in children, which occurred in 39 patients in this sample. 25 Cutaneous calcifications were found more frequently in JDM (26% of cases) compared to adult DM (p = 0.002), corroborating the findings of Pachman et al. 23 , which recorded a calcification rate of 23% in JDM, and Sang-Jun et al., with 37.5% of cases. Skin lesions were present in 100% of the assessed patients.
15
The most common muscle alteration was strength loss, occurring in 88% of the cases. Most reviewed studies describe a higher percentage of myalgia in relation to arthralgia, as exemplified by Maugers et al., with myalgia's incidence of 59.4% and arthralgia's rate of 46.4%.
11 A peculiar fact is that, in the present study, arthralgia was the most common complaint, occurring in 30.2% in adult DM and 12.8% of the cases in JDM in consonance with the results reported by Hochberg et al. 56 and Pinto et al. 46 which reported 29% and 62% of arthralgia rates in patients, respectively.
In general, the association between DM and interstitial lung disease occurs in about 5-30% of the cases reported in the literature, initially with flu-like symptoms, fever, and later with dyspnea. 57 Chest radiography and computed tomography show irregular and linear opacities bilaterally, with involvement of lung bases and occasional consolidations in the affected sites. A study performed in Minnesota with 973 patients presenting DM/PM demonstrated the association with interstitial lung disease in 70 of them; in Germany, 63 patients were evaluated, 20 of which (32%) developed interstitial lung disease and Schiopu et al. found 16 such cases among 83 patients. 17, 57, 58 In this service, computed tomography is requested only when the patient presents pulmonary symptoms or alterations during clinical examination. The most frequent pulmonary disorder was interstitial lung disease, affecting 18 patients (16.5%), followed by bacterial pneumonia, with eight cases (7.3%), which was the cause of death of four patients.
Likewise, endoscopy was only requested for those presenting digestive symptoms. Gastritis was the gastrointestinal tract disorder that occurred more frequently (20.2%), probably secondary to the use of corticosteroids, used in most cases in our service to control the disease. Esophageal hypotonia was diagnosed in 12 patients, but it did not occur in patients with JDM. Intestinal parasitosis, common in our midst, was diagnosed in nine cases, and early detection and appropriate treatment are important to prevent major complications during immunosuppressive therapy.
Previous studies reported CK and aldolase as the serum enzymes most sensitive for DM diagnosis; our results revealed the importance of not only these two enzymes, but also of LDH, which was elevated in 78.6% of the evaluated cases. 7, 9 It is known, however,
